<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WHO-HEM5 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/who-hem5/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Oct 2026 11:05:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>WHO-HEM5 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Leukemia That Refuses to Choose: The Science of Mixed Phenotype Acute Leukemia</title>
		<link>https://bioengineer.org/leukemia-that-refuses-to-choose-the-science-of-mixed-phenotype-acute-leukemia/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 18 Oct 2026 11:05:44 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[acute leukemia]]></category>
		<category><![CDATA[BCR::ABL1]]></category>
		<category><![CDATA[Hematology]]></category>
		<category><![CDATA[International Consensus Classification]]></category>
		<category><![CDATA[KMT2A]]></category>
		<category><![CDATA[lineage plasticity]]></category>
		<category><![CDATA[measurable residual disease]]></category>
		<category><![CDATA[mixed phenotype acute leukemia]]></category>
		<category><![CDATA[MPAL]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Venetoclax]]></category>
		<category><![CDATA[WHO-HEM5]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=434534</guid>

					<description><![CDATA[A new review in Cancer Cell International synthesizes contemporary classification, clonal biology, and precision therapy for mixed phenotype acute leukemia, arguing that management must track the founding clone across phenotypic states rather than rely on static lineage labels.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">434534</post-id>	</item>
	</channel>
</rss>
